Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
International Journal of Cancer|May 18, 2010
Methylation patterns in cell-free plasma DNA reflect removal of the primary tumor and drug treatment of breast cancer patientsThomas E Liggett, Anatoliy A Melnikov, Jeffrey R Marks, et al.
Experimental Cell Research|March 31, 2000
Dispersive initiation of replication in the Chinese hamster rhodopsin locusP A Dijkwel, L D Mesner, V V Levenson, et al.
The Journal of Biological Chemistry|November 20, 2010
Prolylcarboxypeptidase regulates proliferation, autophagy, and resistance to 4-hydroxytamoxifen-induced cytotoxicity in estrogen receptor-positive breast cancer cellsLei Duan, Natalia Motchoulski, Brian Danzer, et al.
Journal of Surgical Oncology|December 10, 2008
Methylation profile of circulating plasma DNA in patients with pancreatic cancerAnatoliy A Melnikov, Denise Scholtens, Mark S Talamonti, et al.
The Journal of Molecular Diagnostics : JMD|January 1, 2008
Array-based multiplex analysis of DNA methylation in breast cancer tissuesAnatoliy A Melnikov, Denise M Scholtens, Elizabeth L Wiley, et al.
Cancer Biology & Therapy|October 12, 2020
Prolyl endopeptidase inhibitor Y-29794 blocks the IRS1-AKT-mTORC1 pathway and inhibits survival and in vivo tumor growth of triple-negative breast cancerRicardo E Perez, Sarah Calhoun, Daeun Shim, et al.
Nucleic Acids Research|June 10, 2005
MSRE-PCR for analysis of gene-specific DNA methylationAnatoliy A Melnikov, Ronald B Gartenhaus, Anait S Levenson, et al.
The Journal of Biological Chemistry|June 18, 2014
The prolyl peptidases PRCP/PREP regulate IRS-1 stability critical for rapamycin-induced feedback activation of PI3K and AKTLei Duan, Guoguang Ying, Brian Danzer, et al.
Somatic Cell and Molecular Genetics|August 5, 2000
A combination of genetic suppressor elements produces resistance to drugs inhibiting DNA replicationV V Levenson, E Lausch, D J Kirschling, et al.
Cell Cycle (Georgetown, Tex.)|April 11, 2012
Methylation of death-associated protein kinase is associated with cetuximab and erlotinib resistanceTakenori Ogawa, Thomas E Liggett, Anatoliy A Melnikov, et al.
Pageof 3